Strategy – Talk Bio

Zymeworks Pivots to Royalty-Driven Model After Strong Ziihera Data in Gastric Cancer

3 weeks ago talkbio0Tagged Biological Factors, buyback, erbB-2 Receptor, Jazz, Malignant neoplasm of stomach, milestone payments, Regulatory Filing, Royalty-Driven Model, Strategy, Ziihera, Zymeworks

Zymeworks; royalty-driven model; Ziihera; gastric cancer; HER2; biologics; milestone payments; stock buyback; biotech strategy; Jazz Pharmaceuticals; regulatory filing

CDC Launches ‘Free Mind’ Campaign Targeting Teen Substance Use and Mental Health

4 months ago talkbio0Tagged Adolescence, Alcohol or Other Drugs use, Centers for Disease Control and Prevention (U.S.), Drug Overdose, fentanyl, Free Mind ' Campaign, mental health, Strategy, teen suicide

CDC; Free Mind campaign; youth mental health; substance use; drug overdose; fentanyl; teen suicide; coping strategies

Acelyrin Shifts Focus Amid Izokibep Setbacks, Lays Off Staff to Pursue Tepezza’s Market Share

1 year ago talkbio0Tagged Acelyrin, Clinical Trials, Izokibep, Market, setbacks, Strategy, Tepezza

Acelyrin, izokibep, clinical trial setbacks, layoffs, Tepezza, market strategy

Pfizer Appoints Citi Analyst Andrew Baum as New Strategy Chief

2 years ago talkbio0Tagged Andrew Baum, Chief, Citi, Drug Industry, Leadership Change, Pfizer, Strategic Planning, Strategy

Pfizer, Andrew Baum, Citi analyst, strategy chief, pharmaceutical industry, leadership change, strategic planning.